Sfoglia per AUTORE
CHIARA S
Collezione ASL Biella

  

Items : 6

The Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) Global Surgical Collaboration Project: Development of Criteria for Reporting Adverse Events During Surgical Procedures and Evaluating Their Impact on the Postoperative Course. in European urology focus / Eur Urol Focus. 2022 Nov;8(6):1847-1858. doi: 10.1016/j.euf.2022.01.018. Epub 2022 Feb 15.

2022
ASL Biella
AOU Città della Salute di Torino
AOU Novara

Artibani W; Desai M; Zaramella S; Lebastchi A; Sotelo R; Shekhar Biyani C; Mitropoulos D; Abreu A; Volpe A; Verze P; Veneziano D; Varca V; Umari P; Schiavina R; Sciorio C; Pucci L; Porreca A; Pini G; Greco F; Minervini A; Parma P; Chiara Sighinolfi M; Pastore AL; Gallo F; Falsaperla M; Galfano A; Falabella R; Dalpiaz O; Crivellaro S; et alii...

Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer. in British journal of cancer / Br J Cancer. 2017 Jan;116(3):318-323. doi: 10.1038/bjc.2016.413. Epub 2017 Jan 12.

2017
ASL Biella
AO Cuneo

Cremolini C; Falcone A; Boni L; Tomcikova D; Paris M; Bonetti A; Martignetti A; Dargenio F; Miraglio E; Amoroso D; Banzi MC; Borelli B; Chiara S; Loupakis F; Masi G; Allegrini G; Barbara C; Salvatore L; Antonuzzo L; Marmorino F;

Lactate dehydrogenase (LDH) levels to predict benefit from the continuation of bevacizumab (bev) beyond progression in metastatic colorectal cancer (mCRC): Subgroup analysis of the randomized BEBYP study in Journal of Clinical Oncology

2016
ASL Biella

Marmorino F; Cremolini C; Loupakis F; Barbara C; Dargenio F; Miraglio E; Masi G; Salvatore L; Marcucci L; Antonuzzo L; Chiara S; Banzi C; Schirripa M; Amoroso D; Bonetti A; Martignetti A; Paris M; Boni L; Tomcikova D; Falcone A;

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer in Annals of Oncology

2014
ASL Biella
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 2

Bajetta E; Floriani I; Di Bartolomeo M; Labianca R; Falcone A; Di Costanzo F; Comella G; Amadori D; Pinto C; Carlomagno C; Nitti D; Daniele B; Mini E; Poli D; Santoro A; Mosconi S; Casaretti R; Boni C; Pinotti G; Bidoli P; Landi L; Rosati G; Ravaioli A; Cantore M; Di Fabio F; Aitini E; Marchet A; Rulli E; Cropalato Di Tullio M; et alii...

Italian observational study in patients with metastatic colorectal cancer (mCRC) treated with first-line cetuximab based regimen (ObservEr study) in Journal of Clinical Oncology

2014
ASL Biella

Di Fabio F; Rosati G; Lolli IR; Ruggeri EM; Ciuffreda L; Ferrari D; Tumolo S; Rosti G; Tralongo P; Ferrara R; Alabiso O; Chiara S; Ianniello GP; Di Costanzo F; Frassoldati A; Iacono C; Clerico M; Pavesi L; Bernardo G; Pinto C;

Aprepitant (AP) versus dexamethasone (D) for preventing delayed emesis induced by anthracyclines plus cyclophosphamide (A+C) chemotherapy (CT) in breast cancer patients (pts): A double-blind, multicenter, randomized study in Journal of Clinical Oncology

2013
ASL Biella
AOU Città della Salute di Torino

Roila F; Ballatori E; Fabi A; Fatigoni S; Chiara S; Ionta MT; Aieta M; Clerico M; Palladino MA; Indelli M; Garrone O; Bustreo S; Ruggeri B;